REFERENCES
- Chambers J. E., Oppenheimer S. F. Organophosphates, serine esterase inhibition, and modeling of organophosphate toxicity. Toxicol. Sci. 2004; 2(77)185–187
- Childs A. F., Davies D. R., Green A. L., Rutland J. P. The reactivation by oximes and hydroxamic acids of cholinesterase inhibited by organo-phosphorus compounds. Br. J. Pharmacol. 1955; 10: 462–465
- Dohnal V., Kuča K., Jun D. Prediction of a new broad-spectrum reactivator capable of reactivating acetylcholinesterase inhibited by nerve agents. J. Appl. Biomed. 2005; 3: 139–145
- Ellman G. L., Courtney K. D., Andres V., Jr., Featherstone R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961; 7: 88–95
- Fleisher J. H., Harris L. W. Dealkylation as a mechanism for aging of cholinesterase after poisoning with pinacolyl methylphosphonofluoridate. Biochem. Pharmacol. 1965; 14: 641–650
- Helden H. P. M., Busker R. W., Melchers B. P. C., Bruijnzeel P. L. B. Pharmacological effects of oximes: How relevant are they. Arch. Toxicol. 1996; 70: 779–786
- Hobinger F., Sadler P. W. Protection against lethal organophosphate poisoning by quaternary pyridine aldoximes. Br. J. Pharmacol. 1959; 14: 192–201
- Ordentlich A., Barak D., Kronman Ch., Ariel N., Segall Y., Velan B., Shafferman A. The architecture of human acetylcholinesterase active center probed by interactions with selected organophosphate inhibitors. J. Biol. Chem. 1996; 271(20)11953–11962
- Poziomek E. J., Hackley B. E., Jr., Steinberg G. M. Pyridinium aldoximes. J. Org. Chem. 1958; 23: 714–718
- Tušarová I., Halámek E. Biosenzor pro detekci a rozlišení inhibitorů cholinesteráz, způsob prípravy zóny biosenzoru s imobilizovanou cholinesterázou, způsob detekce inhibitoru cholinesteráz a způsob rozlišení inhibitorů cholinesteráz. Czech Patent No. 288576, 2001
- Wilson I. B., Ginsburg S. Reactivation of acetylcholinesterase inhibited by alkylphosphonates. Arch. Biochem. Biophys. 1955; 54: 269–271